| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
2 companies
Mihir Shah last filed a Form 4 in May 2024, as Chief Financial Officer at TOI. The filings on record cover 2 companies. Mihir Shah's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 19,932 shares of ASTH.
Mihir Shah has 9 Form 4 filings on record from November 2016 to May 2024, across 2 companies: Chief Financial Officer at Oncology Institute (TOI), 2022–2024; Chief Financial Officer at Astrana Health (ASTH), 2016–2018.
The 16 reported transactions were 6 option or other derivative awards, 4 stock awards, 2 open-market purchases and 2 dispositions back to the company, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 1 purchase worth about $127K and no sales.
The only open-market purchase was 100,000 shares of TOI at an average $1.27 on December 14, 2023, about $127K. Twelve months later TOI was down 82%.
Shares as reported in the last Form 4 for each company; the most recent is from May 2024. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 14, 2023 | TOI Oncology Institute, Inc. | Chief Financial Officer | Buy | 100,000 | $1.27 | $126,988.70 | +43.8% | +42.4% | -82.2% |